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Abstract 
Objective: Routine outcome monitoring (ROM) is a well-evidenced means of 
improving psychotherapy’s effectiveness. However, it is unclear how meaningful ROM 
is for problems that span physical and mental health, such as severe health anxiety. 
Physical and mental health comorbidities are common amongst severe health anxiety 
sufferers and cognitive behavioral therapy (CBT) is a recommended treatment. 
Method:  Seventy-nine participants received CBT for severe health anxiety in a clinical 
trial. The Outcome Rating Scale (ORS: a ROM assessment of wellbeing) was 
completed at each session. Multilevel modelling assessed whether last-session ORS 
predicted health anxiety and other outcomes over 12-month follow-up. Similar models 
were developed using health anxiety as a comparative outcome-predictor. Outcome-
improvements of treatment-responders with sudden gains were compared to those of 
non-sudden-gainers. Results: Last-session ORS scores predicted all outcomes up to 12 
months later, with a comparable predictive effect to health anxiety. Sudden-gainers on 
the ORS reported significantly greater improvement in depression, functioning, and 
wellbeing, but no difference in health anxiety or other measures. Conclusion: The ORS 
may be a feasible, overall estimate of health, functioning, and quality of life in 
psychotherapy for severe health anxiety. Sudden gains on the ORS may be clinically 
meaningful with respect to some long-term outcomes. 
Keywords: Routine outcome monitoring; outcome feedback; feedback-informed 
treatment; cognitive behavioral therapy; health anxiety; comorbidity. 
Word count: Abstract: 200; Main text: 6263 
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Routine outcome monitoring is an umbrella term used to describe methods in which an 
outcome assessment is given, typically at every session of psychotherapy, and resultant 
scores give therapists algorithm-based predictions of treatment outcome (Lambert, 2010). 
This aims either to alert therapists to patients who are at risk of having a poor outcome or to 
help patients and therapists collaborate to enhance improvement. With appropriate training 
and supervision, psychotherapists can tailor therapy to the outcome trajectory of individual 
patients. As such, ROM becomes more than an assessment method and can be seen as an 
intervention in its own right. Current evidence from Randomized Controlled Trials (RCTs) 
and subsequent meta-analyses suggest that ROM can have beneficial effects for both 
treatment efficacy and efficiency (Delgadillo et al., 2018; Lambert, Whipple, & Kleinstäuber, 
2018; Shimokawa, Lambert, & Smart, 2010). The two best-evidenced ROM tools use 
general, overall assessments of mental health and wellbeing: The Outcome Questionnaire 45 
items (OQ-45; Lambert, 2012) and the Outcome Rating Scale (ORS; Miller, Duncan, Sorrell, 
& Brown, 2005). Both systems aim to give an overview outcome assessment which can be 
used across conditions, identifying the “mental health vital signs” (Lambert et al., 2018, p. 
520). They are designed for mixed, general populations and have typically been evaluated in 
routine practice settings.  
The ORS is the central outcome measure in the Partners for Change Outcome 
Measurement System (PCOMS; Miller et al., 2005). A more nuanced understanding of 
PCOMS effects has emerged from recent meta-analyses (Lambert et al., 2018; Østergård, 
Randa, & Hougaard, 2018). The PCOMS system has been shown to have beneficial effects 
on outcome as compared to usual care and reduces the number of patients showing no 
improvement at the end of treatment. However, it does not reduce the number of patients 
dropping out or deteriorating. Furthermore, Østergård et al. (2018) found that PCOMS only 
had a beneficial treatment effect when outcome was measured with the ORS, but not when 
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independent measures were used. The same was found in three studies using independent 
outcome measures in the nine-study sample investigated by Lambert, Whipple, and 
Kleinstäuber (in-press). This illustrates a central unaddressed issue within ROM research: 
The unclear relationship between ROM outcomes and other important independent outcomes. 
Unaddressed issues in ROM 
The case is presented specifically for PCOMS, but in many RCTs assessing the effectiveness 
of ROM, there have been criticisms for using the ROM measure as the primary outcome 
(Wampold, 2015). This means that the ORS is frequently used both as the ROM intervention 
and the outcome of the ROM intervention, meaning one cannot tell the independent value of 
ROM interventions. Even when independent assessments are used, they are typically general 
in nature with few studies including assessment of quality of life, functioning, or disorder-
specific outcomes (Kendrick et al., 2014). Furthermore, ROM RCTs and meta-analyses have 
almost all been directly or indirectly conducted by researchers with an allegiance to the 
method investigated, which tends to inflate effectiveness (Luborsky et al., 1999). This is 
supported by evidence that RCTs carried out more independently have sometimes had less 
positive results (e.g. Rise, Eriksen, Grimstad, & Steinsbekk, 2016). Another element 
commonly missing from ROM research is independently-assessed, longer-term outcome 
follow-up (Kendrick et al., 2014). As ROM studies often use outcome data collected by 
therapists during treatment, there are fewer studies where outcome data are collected by 
independent or blinded assessors at fixed intervals after treatment (Østergård et al., 2018). 
The absence of independent longer-term follow-up or blinding is another factor likely to 
inflate the treatment effect, due to both assessor bias and the potential for treatment effects to 
diminish after completion (Wood et al., 2008).  
ROUTINE OUTCOME MONITORING AND HEALTH ANXIETY   5 
 
Comorbidity and ROM 
From this type of evidence, it is difficult to assess the independent predictive ability of ROM 
measures on treatment outcomes for specific disorders, which usually lack relevant 
assessments and are typically conducted by those with an allegiance. This situation is 
especially problematic in mental health problems that commonly co-occur with physical 
health problems, as key outcomes would not be assessed by ROM measures. Comorbidity of 
this type leads to poorer health outcomes for patients and higher costs for services (Barnett et 
al., 2012; Naylor et al., 2016). Demonstrating that a commonly-used ROM tool is predictive 
of more specific independently-assessed physical and mental health outcomes would expand 
our understanding of the value such ROM assessments hold. However, it is unclear whether 
the most widely-used ROM measures (such as the ORS) can effectively assess the types of 
outcome that are important where comorbid physical and mental health problems are present. 
Therefore, patients who appear to be improving on ROM measures may not improve in 
important unassessed areas to which the clinician is blind. Alternatively, the tailored care 
which is integrated within ROM systems may make ROM meaningful even for problems 
with physical and mental health sequelae, such as severe health anxiety.  
Severe health anxiety and comorbidities 
Cognitive behavioral therapy (CBT) has proven effective for mental health problems that are 
frequently comorbid with chronic physical health problems; severe health anxiety being one 
of the most common examples (e.g. Tyrer et al., 2017). Severe health anxiety can be defined 
as an anxious preoccupation with having or contracting a serious health problem, which is not 
resolved by medical reassurance (Fink et al., 2004). It affects approximately 5.7% of the 
population across a lifetime and is associated with multimorbid, chronic physical and mental 
health problems (Patel et al., 2015; Sunderland, Newby, & Andrews, 2013). Symptoms of 
severe health anxiety are characterized by an interplay between physical and psychological 
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difficulties. For example, persistent bodily checking is an identified factor maintaining severe 
health anxiety, wherein fear of bodily symptoms (such as pain) leads to recurrent body 
checking. However, repeatedly checking the body exacerbates symptoms such as pain; thus, 
pain is worsened and anxiety consequently maintained (Salkovskis & Warwick, 1986). Given 
this interaction, if severe health anxiety were to improve, one might expect concurrent 
improvement in general health too (Morriss et al., 2019) . Yet this type of change may not be 
picked up in routine practice using ROM. Conversely, ROM may give a false indication of 
improvement when core symptoms remain. Therefore, it is unclear whether ROM tools can 
make a meaningful contribution to psychotherapy outcome assessment of specific disorders, 
such as health anxiety, which often involve comorbid physical and mental health problems. 
Independent assessment of a range of outcomes over time would give a clearer understanding 
of the value ROM may hold for specific disorders, especially comorbid physical and mental 
health disorders.  
Sudden gains and ROM 
A similar situation is apparent with sudden gains in ROM: Sudden gains have been identified 
from ROM data, but it is unclear whether they translate into improvements on other outcomes 
(Lambert, 2010). Sudden gains are defined as large, sustained, clinically meaningful 
improvements in symptoms, typically occurring early in psychological treatment (Tang & 
DeRubeis, 1999). Those experiencing sudden gains often have better long-term outcomes 
than those without (Aderka, Nickerson, Bøe, & Hofmann, 2012). This has been most clearly 
evidenced in CBT for depression (Tang, DeRubeis, Beberman, & Pham, 2005; Tang, 
DeRubeis, Hollon, Amsterdam, & Shelton, 2007). Beneficial effects of sudden gains have 
also been evidenced in severe health anxiety, but eligibility criteria restricted the likelihood of 
comorbidity and no outcome assessments were taken for other disorders (Hedman et al., 
2014). Little crossover research has been conducted between sudden gains in disorder-
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specific outcomes and those occurring on ROM tools. As such, it is unclear whether sudden 
gains on ROM tools have any impact on long-term disorder-specific outcomes. Moreover, 
sudden gains have not been studied in populations with high rates of comorbidity. Thus, it is 
unclear whether the phenomenon still has clinical significance where multiple problems are 
present or what outcome measures are best for assessing sudden gains in this context. 
This study assessed the predictive validity of a ROM assessment (the ORS) on long-
term health anxiety severity measured independently up to 12 months after CBT for high 
service utilizers with severe health anxiety (Morriss et al., 2019) . The study also assessed the 
predictive value of ROM on other anticipated effects of severe health anxiety: overall health, 
functional impairment, quality of life, somatic symptoms, generalized anxiety, and 
depression. Lastly, this study assessed whether sudden gains in ROM have a significant 
impact on long-term trajectories of health anxiety and the other outcomes. 
Method 
Design and participants 
The predictive value of the ORS for a range of independently-assessed health outcomes over 
time was assessed by an observational design.  The study applied a secondary analysis to data 
from a single-blind, two-armed RCT evaluating the effectiveness of remotely delivered CBT 
for high service utilizers with severe health anxiety compared to treatment as usual (TAU) 
(Morriss et al., 2019). In the original RCT, 156 adult participants with severe health anxiety 
attending two or more urgent care appointments over the previous 12 months and 
experiencing severe health anxiety were equally randomized to CBT or TAU. Participants 
were recruited by treating healthcare professionals from primary and general hospital care 
(including emergency care, endocrinology, and neurology departments) with most 
participants seeking physical (rather than mental) health treatment. Severe health anxiety was 
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identified via screening with the short-form health anxiety inventory (SHAI) administered by 
independent researchers. Those scoring  ≥18 on the SHAI were classified as severely health 
anxious using established clinical cut-off criteria (Clark & Oates, 2014). All 791 participants 
receiving CBT were offered weekly CBT adapted to severe health anxiety over video 
conferencing or the telephone. All those attending sessions were offered the use of ROM by 
their therapists with the ORS completed at each session. In parallel, a series of physical and 
mental health outcome assessments were taken at baseline, 3-, 6-, 9-, and 12-month follow-up 
by independent researchers blinded to treatment group. The study showed that, at 12-month 
follow-up, those offered CBT had significantly greater reductions in health anxiety, 
generalized anxiety, and depression, and greater improvements in general health. 
Furthermore, the intervention resulted in a net monetary benefit of £3,164 over usual care, 
due to the reduction in healthcare-use over the year amongst CBT recipients. 
 Fifty-six participants (71%) in the treatment arm attended two or more sessions of 
CBT and completed the ORS. All were included in the first stage of this study, to assess 
whether the ORS score at the final session predicted follow-up health outcomes. The 
predictive validity of the ORS was directly compared to 6-month follow-up assessment of 
health anxiety as a predictor of all secondary outcomes. The 57 participants who had 
responded to treatment at follow-up were included in a sensitivity assessment: Those who 
responded to treatment and experienced a sudden gain on the ORS were compared to the 
remaining treatment responders to see if sudden gains in routinely-monitored outcomes 
conferred a long-term clinical benefit.  
                                                 
1 There were 78 participants randomized to CBT, and one participant was randomized to usual care but offered 
CBT in error: Their data is included in the analysis; therefore, the total sample is 79. 
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Instruments  
Routine Outcome Monitoring 
The ORS and associated PCOMS is one of the most widely used ROM systems, with 
approximately 45,000 therapists registered across 20 countries (Østergård et al., 2018). It is 
designed for use in all healthcare settings but has predominantly been evidenced in routine 
care psychotherapy populations (Lambert et al., 2018). It is designed with the primary aim of 
improving overall effectiveness for all patients by improving patient engagement in the 
treatment. No researchers in the current study or original RCT have any allegiance to 
PCOMS or other ROM systems. 
The ORS uses four self-reported, brief visual analogue scales, which aim to assess the 
central targets of psychological treatment: individual wellbeing, change in relationships, 
social functioning, and overall wellbeing (Miller, Duncan, Brown, Sparks, & Claud, 2003).  
In normal use of the ORS, each scale is rated 0 to 10 and the scores are totaled out of 40. 
Increasing scores indicate improved wellbeing. Scores below the clinical cut-off of 25 fall 
within the established clinical range (Prescott, Maeschalck, & Miller, 2017). The ORS has 
shown excellent internal consistency (α = .93); adequate test-retest reliability (rs = .49 - .66) 
and satisfactory convergent validity with the OQ-45 (rs = .56 - .69) (Miller et al., 2003).  
Independent Assessments 
Due to high rates of comorbidity amongst those with severe health anxiety, a range of 
outcomes were assessed independently: 
 The 14-item SHAI (Salkovskis, Rimes, Warwick, & Clark, 2002). 
 7-item Generalized Anxiety Disorder assessing generalized anxiety (GAD-7) (Spitzer, 
Kroenke, Williams, & Löwe, 2006).  
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 15-item Patient Health Questionnaire assessing somatic distress (PHQ-15) (Kroenke, 
Spitzer, & Williams, 2002). 
 9-item Patient Health Questionnaire assessing symptoms of depression (PHQ-9) 
(Kroenke, Spitzer, & Williams, 2001). 
 8-item Work and Social Adjustment Scale (WSAS) assessing functional impairment 
(Mundt, Marks, Shear, & Greist, 2002). 
 5-item 5-level EuroQol assessing quality of life (EQ5D-5L; Herdman et al., 2011). 
 Visual analogue scale (VAS, Herdman et al., 2011) assessing general health. 
The structured clinical interview for the Diagnostic and Statistical Manual of Mental 
Disorders IV (SCID; First, Spitzer, Gibbon, & Williams, 1998) was also administered at 
baseline. Long-term physical health conditions were recorded from baseline patient 
interviews. 
 The approach used mitigates common methods variance in some ways when 
associating the ORS with other outcomes. In most outcome prediction studies, both the 
predictor and outcome measurements are completed with the same assessors, which is likely 
to inflate associations (Campbell & Fiske, 1959), whereas in the current study, the ORS uses 
a visual analogue scale completed with therapists to compare with questionnaire-based 
measures (with the exception of the VAS) completed with independent researchers. This 
reduces the likelihood of inflated associations and type-I errors. 
Procedure 
Remote CBT 
Remote CBT was delivered via video conferencing or over the telephone if internet access 
was limited. A team of four therapists delivered treatment according to an established 
treatment protocol (Tyrer et al., 2017). Six to 12 CBT sessions were offered based on 
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treatment response, with the option of up to three booster sessions (a median eight were 
attended by participants). This included time at the beginning of treatment designated to 
familiarizing patients with the delivery methods to be used and addressing any related 
concerns they might have about this. Patients were sent webcams and audio headsets if 
required to facilitate the use of remote technology. Patients were also sent a written guide for 
use of remote technology and a guide explaining how CBT would be used through remote 
technology to address health anxiety. Treatment used CBT principles to assess and test 
beliefs about health, illness, and associated issues that were likely to be causing distress. 
Behavioural strategies known to maintain severe health anxiety were identified and 
collaboratively reduced or stopped. Typically, treatment order included listing and 
prioritizing health fears (session 1-2); establishing the meaning of these fears to the 
individual (session 1-3); then collaboratively formulating ways in which these fears might be 
maintained by specific behavioral and cognitive strategies (session 2-4); experiments were 
then used to evaluate the impact of changing these strategies (e.g. reducing bodily checking; 
session 2-8); changes in beliefs and behavior were reevaluated as a result (session 3-10; 
relapse prevention plans were then put into place session (6-12). Treatment completion was 
agreed between therapist and patient informed by ROM data and achievement of treatment 
goals. Attending five or more sessions was considered an adequate treatment dose, using 
established criteria unless earlier treatment completion was mutually agreed (Tyrer et al., 
2014). 
Administration of the ORS 
The ORS was completed by patients with their therapist at every session of CBT, unless 
patients refused or did not attend. Therapists used the ORS to tailor treatment by focusing on 
key problems of importance to the patient in each domain and setting goals associated with 
points on the scales. For example, if a patient highlighted social avoidance as a key problem 
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that was reducing the score on the social functioning scale to 3, the therapist might establish 
what would be different if they were functioning ‘at the level of a 4’. They could then work 
towards what the patient describes as a short-term goal. The ORS was completed on software 
which gave a computerized traffic light system (www.myoutcomesukapp.com), alerting 
therapists to patients who were at risk of non-improvement or deterioration, from algorithm 
predicted outcome trajectories (Miller et al., 2005). If patients were identified as at risk of a 
poor outcome, therapists initiated conversations to help identify unaddressed problems and 
collaboratively adjust the course of therapy. All trial therapists used ORS data to identify 
patients on their caseload at risk of poor outcome. They then attended monthly supervision 
focused on addressing issues with these cases in particular, using observation of recordings 
from previous sessions to guide decision-making. 
Method of analysis 
The baseline characteristics of included and excluded patients were compared using Mann-
Whitney U tests for continuous variables and chi-squared for categorical variables. Pearson’s 
correlation coefficients were calculated for associations among baseline outcome scores and 
Spearman’s rho was used to calculate correlations among post-treatment scores (last session 
score for the ORS and 6-month follow-up for all other measures). 
Predictive modelling 
Due to the repeated measurement design, multilevel modelling was used to assess whether 
ORS total scores at the last session separately predicted each health outcome individually. 
Data were structured in a two-level model with repeated follow-up assessment time-point 
(“time” hereafter) at level 1, nested within patients at level 2. A preliminarily-tested third 
(“therapist”) level was not significant on any outcomes. Unconditional models were used to 
assess clustering within patients and linearity of trends before adding explanatory variables. 
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Model fit was explored using -2 log likelihood and parameter estimation was made using 
maximum likelihood. Each parameter was added to the model in a stepped manner. As each 
parameter was added, change in -2 log likelihood and change in degrees of freedom were 
used to calculate whether a significant reduction in model deviance was caused using chi-
squared (summarized in online supplement Table 1). All modelling analyses used observed 
data only, missing data was not imputed. 
 Fully adjusted models included the following fixed predictor variables for each 
outcome: time; baseline outcome score (controlling for baseline outcome severity); first 
session ORS score (controlling for initial ORS severity); total number of mental and physical 
health diagnoses (controlling for comorbidity); and last session ORS score (the main 
predictor of interest). Random intercepts for time were included in all models, but random 
slopes were not. This was either due to non-significance in fully adjusted models or non-
significant change in -2 log likelihood when slope was added (using chi-squared). Below is 
an illustration of the equation tested using health anxiety: 
yij = β0i + β1timeij + β2 Baseline SHAIij + β3 First session ORSij + β4 Total disordersij + β5 Last 
session ORSij + eij                                                                                                              (1) 
β0i = β0 + μi             (2) 
Where yij is the SHAI score for the jth participant at the ith follow-up time point. As such j is 
participants (level 2 unit) and i is follow-up time order (level 1 within level 2 unit). β0i 
indicates that estimates of the intercept for both the overall model and variability of level 1 
intercepts were calculated. β1 through β5 were fixed level 2 effects, adjusting for differences 
between participants. eij is the residual or unexplained variance in the model.  
 The same methods were used to build models with 6-month health anxiety (SHAI) as 
the focal predictor-of-interest for each secondary outcome in turn. This is illustrated below, 
ROUTINE OUTCOME MONITORING AND HEALTH ANXIETY   14 
 
where yij is the generalized anxiety (GAD-7) score for the jth participant at the ith follow-up 
time: 
yij = β0i + β1timeij + β2 Baseline GAD-7ij + β3 Baseline SHAIij + β4Total diagnosesij + β5 6-
month SHAIij + eij                                                                                                                                                                         (3) 
β0i = β0 + μi           (4) 
 Fully adjusted models included the same fixed predictor variables for each outcome with 
SHAI in exchange for ORS: time; baseline outcome score; baseline SHAI; total  
diagnoses; SHAI at 6 months (the focal predictor). Random intercepts, but not slopes, were 
again included in all models. 
Parallel models were constructed to compare the predictive validity of the ORS versus 
SHAI – facilitating evaluation of the predictive ability of the ORS against that of the primary 
treatment target and outcome variable of the trial (SHAI). This comparison was conducted 
using a pseudo-R2, which gives a measure of effect size in multilevel modelling, enabling a 
direct comparison between the ORS and SHAI (Raudenbush & Bryk, 2002). The pseudo-R2 
was calculated as the percentage of: ((σ5
2-σ6
2)/ σ1
2),  where σ1
2 is the unconditional model 
intercept variance (step 1), σ5
2 is intercept variance in the fully adjusted model without the 
focal predictor (step 5) and σ6
2 is the fully adjusted model’s intercept variance (step 6). This 
shows the percentage reduction in unexplained variance between observations when post 
treatment SHAI/last-session ORS are added to fully adjusted models (“full” below) (Hox, 
Moerbeek, & Van de Schoot, 2017): 
𝑃𝑠𝑒𝑢𝑑𝑜 𝑅2 =
(𝑣𝑎𝑟𝑖𝑎𝑛𝑐𝑒 𝑓𝑢𝑙𝑙 𝑤𝑖𝑡ℎ𝑜𝑢𝑡 𝑡𝑎𝑟𝑔𝑒𝑡)−(𝑣𝑎𝑟𝑖𝑎𝑛𝑐𝑒 𝑓𝑢𝑙𝑙 𝑤𝑖𝑡ℎ 𝑡𝑎𝑟𝑔𝑒𝑡)
𝑣𝑎𝑟𝑖𝑎𝑛𝑐𝑒 𝑢𝑛𝑐𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛𝑎𝑙
                                                  (5)                                                                                                                 
Analysis was conducted using SPSS 24.  
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Sudden gains modelling  
An adaptation of Tang and DeRubeis’ (1999) definition of sudden gains was applied to ORS 
scores, assessing large intersessional gains between session N and N + 1 if the following 
criteria were met: 
1. Sudden gains should be large in absolute terms – specifically, the N + 1 gain needed 
to be at least 5 points, the established reliable change index on the ORS. 
2. Sudden gains should be large in relative terms – specifically, the N + 1 gain needed to 
be at least a 25% improvement on session N. 
3. Sudden gains should be sustained beyond random fluctuations – specifically, the 
mean ORS score of the three sessions prior to the gain should be at least a reliable 
change (5 points) lower than the mean ORS score for the three sessions following the 
sudden gain. This criterion was adapted to include sudden gains at the very beginning 
or end of treatment given that treatment in the current study was much briefer than in 
the study from which the criteria originate (16-20 versus 6-12 sessions). Indeed, only 
a sudden gain at session 3 could be identified if the minimum number of sessions 
were attended. This is particularly problematic when sudden gains identified at the 
first session have been found to positively influence outcome in their own right 
(Busch, Kanter, Landes, & Kohlenberg, 2006). Therefore, fewer than three sessions 
prior to the gain were allowed as long as the gain was sustained for the three ensuing 
sessions. Conversely, fewer than three sessions were allowed after a gain assuming 
that the pre-gain score was stable for the previous three sessions. This aimed to 
include very early or late gains which would otherwise be missed.  
 In order to assess whether these adapted criteria were of clinical value, results were 
compared to those achieved using the more strict criteria from the original method: To be 
identified as a sudden gain, the mean ORS score of the three session scores prior to the gain 
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were required to be significantly lower than the three sessions after the gain using an 
independent t-test, with an alpha of .05. Two sessions before and after were used if there 
were no more than two sessions before or after the gain, otherwise three were required. 
 Treatment responders who experienced sudden gains were compared to treatment 
responders who did not experience sudden gains. Treatment responders were defined as those 
experiencing ≥ 4 point reduction in health anxiety score at follow-up, as this is deemed the 
minimum clinically important change index on the SHAI (Clark & Oates, 2014). Multilevel 
modelling was again used to account for the hierarchical structure of level 1 time clustered 
within level 2 patients. Similar methods of model development as previously described were 
used. Random intercepts and fixed slopes for time were included in all models. Four fixed 
predictors were entered as covariates into models for each model: time, baseline outcome 
score, total diagnoses and sudden gains (a binary variable assessing the difference in growth 
curves over time of those identified as sudden gainers versus remaining treatment 
responders). As well as independently-assessed outcomes over 12-month follow-up, a model 
was developed which used session-by-session ORS scores as the ordered time parameter. 
This model evaluated whether sudden gainers had significantly improved ORS trajectories 
during treatment sessions. 
 Ethical approval was obtained from the National Research Ethics Service, London-
Riverside Committee (reference 14/LO/1102). 
Results 
Sample characteristics 
There was a greater proportion of females included in the assessment of the ORS’ predictive 
validity than amongst those without available data (χ2 = 3.95, p = .047). No other 
demographic or clinical characteristics were significantly different at baseline (online 
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supplement Table 2). Average baseline scores in the overall sample fell within the clinical 
range on all assessments, including the ORS. Quality of life and general health were both 
lower than average. Diagnostic self-report assessments indicated that comorbid physical and 
mental health problems were very common in the sample, with a mean of 6 (range: 0–16) 
mental disorders and 1 (range: 0–3) chronic physical condition at baseline. 
Outcome Correlations 
Significant weak-to-moderate correlations were observed between first-session ORS scores 
and baseline scores for other outcome measures in the expected directions (absolute rs = .293. 
- .496), except for a lack of correlation with baseline health anxiety (absolute rs = .055 – 
.502). Weak-to-moderate correlation was found between baseline health anxiety (SHAI) and 
generalized anxiety (GAD-7; r = .389), but no correlations were observed with any other 
outcomes. No correlations between last-session ORS and other post-therapy outcome 
measures were of more than moderate magnitude (absolute rss = .310 – .446). A similar 
pattern of significant weak-to-moderate correlations were observed between 6-month follow-
up health anxiety and other post-treatment outcomes (absolute rs = .286 - .520). As last-
session ORS scores were not highly correlated with independently-assessed outcomes at pre- 
or post-therapy assessment-points, the ORS does not seem to be acting as a simple proxy for 
other outcome scores, so investigation of the predictive relationship is warranted. 
Predictive validity of the ORS 
In unconditional models for all outcomes 59% to 79% of the covariance was explained by 
clustering within patients, indicating that a two-level hierarchical structure was appropriate to 
account for this effect. Last-session ORS scores significantly predicted health anxiety over 
time. This meant that improvement on the ORS (higher scores) predicted lower severity of 
health anxiety (lower scores). The same was true of depression, generalized anxiety, somatic 
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symptoms, and functional impairment. Significant positive associations were found between 
last-session ORS scores and quality of life. Therefore, improvement on the ORS predicted 
improvement in quality of life and the same was true of general health. All models controlled 
for baseline ORS, baseline outcome score, number of comorbidities, and changes over time 
(Table 1, data on full models are presented in the online supplement Table 3). 
[Table 1] 
Comparison between the ORS and SHAI 
The same models were run with the SHAI as focal predictor, which demonstrated that it was 
also a significant predictor of all secondary outcomes over time when controlling for baseline 
severity. The percentage reduction in unexplained between-participant variance uniquely 
accounted for by the ORS and SHAI were compared for each model, to give an estimate of 
comparative effect size (Table 2). This analysis indicated that a similar proportion of outcome 
variance was explained by the ORS and the SHAI across outcomes (average 19% and 18% 
respectively). 
[Table 2] 
Sudden gains  
Thirty-two (56%) of the 57 treatment responders (72% of total treatment group) were 
identified as sudden gainers using the adapted criteria. Session 2 was the median session for 
sudden gains to occur (IQR 1–3). The average sudden gain led to a 53% increase in ORS 
score and accounted for 80% of the average sudden gainer’s pre- to post-therapy 
improvement (Figure 1). Multilevel modelling was used to establish whether there was a 
significant difference in outcomes over time for sudden gainers versus non-sudden gaining 
treatment responders. This analysis showed that sudden gainers had significantly greater 
improvement in wellbeing over the course of therapy (B = 4.38, SE B = 1.36, p = .002). 
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Sudden gainers also reported significantly greater improvements in functional impairment 
(WSAS; B = -4.38, SE B = 1.84, p = .021) and symptoms of depression (PHQ-9; B = -2.54, 
SE B = 1.20, p = .039) over the 12-month follow-up period. There were trends for greater 
improvements across all outcomes, though no others reached significance. Figure 2 shows the 
percentage improvement achieved by sudden gainers as compared to other treatment 
responders using baseline scores as the percentage denominator. All models controlled for 
baseline ORS score, baseline outcome score, number of comorbidities and repeated 
measurement effects.  
 Using the strict original criteria for classifying sudden gains, 9 (16%) sudden gainers 
were identified and no differences were observed on any outcome (all ps ≥ .320). The 
allowance for gains at the earliest and latest points in therapy accounted for the vast majority 
of those not identified by the strict criteria. In the analysis using the adapted criteria, 22 
sudden gains were identified before the third session and two further sudden gains at the final 
session.  
Discussion 
Predictive validity of the ORS 
This study used longitudinal, independent, single-blinded assessments to evaluate the 
predictive validity of ORS ratings on a range of health outcomes from CBT for health 
anxiety. Findings suggest that ORS scores at the last treatment session predict a range of 
longer-term physical and mental health outcomes, irrespective of how many sessions were 
attended. Furthermore, the multilevel modelling design means that this relationship is less 
likely to be due to covariance across time, an artefact of baseline problem severity, or related 
to the number of comorbidities. This is a significant expansion in the use of the ORS as a 
common ROM outcome measure, because ORS outcome studies are often clinician-assessed 
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with short follow-up periods. The assessments used in previous ORS studies have also been 
limited in what they can say about the relevance of ROM for specific disorders or its impact 
on general health (rather than just mental health) and quality of life.  
This study indicates that those ending CBT for health anxiety with higher ORS scores 
relative to their baseline score are more likely to sustain long-term improvement in a range of 
health domains. Conversely, those who end treatment with lower ORS scores are unlikely to 
spontaneously improve further down the line. Therefore, therapists and other members of 
relevant patients’ care-teams should be alert to the need for alternative interventions if 
psychotherapy offered was either not accepted or not effective. Consequently, ORS scores at 
the last treatment session may offer a broad, brief assessment of long-term health and quality 
of life after treatment. Given that the source data came from remote delivery of CBT via 
video conferencing or the telephone, this suggests that ROM may be a helpful predictor of 
outcome when using this modality. 
 Comparable post-treatment predictive abilities were achieved for the ORS and health 
anxiety assessments, which may be explained by an overlap in the construct of general 
psychological distress. As health anxiety was both the primary outcome and the main 
treatment target for CBT interventions, this suggests that the more general ORS can have a 
cross-cutting predictive effect that is similar to more specific measures. The findings imply 
that a brief, general ROM assessment like the ORS may be useful to services if choosing 
between general and specific ROM measures. A general ROM assessment would also avoid 
the need to select disorder-specific measures for each patient. Importantly, and novel to ROM 
research, predictive validity was demonstrated across a wide range of outcomes – 
encompassing mental health, physical health, quality of life and functional impairment. 
Therefore, cross-domain outcome prognosis could be estimated, which could be particularly 
important for services offering psychological therapies in physical healthcare settings. 
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Nonetheless, current evidence suggests that disorder-specific feedback can enhance outcomes 
(Clark et al., 2018; Nugter et al., 2017). Given the similar predictive validity and the 
established benefit of disorder-specific feedback, decisions about using either or both will be 
dependent on service context. 
Predictive validity of sudden gains 
Amongst treatment responders, sudden gains on the ORS were associated with greater 
improvements compared with non-sudden gainers. There were significantly greater 
improvements in ORS-rated wellbeing across therapy sessions and significant improvements 
in depression and functioning across 12-month follow-up. These findings add to the extensive 
literature emphasizing the importance of sudden gains for long-term benefits of 
psychotherapy (Aderka et al., 2012). This study also suggests that session-by-session ORS 
changes are somewhat sensitive to specific clinical changes in symptomatology – given that 
rapid, large, sustained ORS improvements correspond with greater long-term improvement in 
clinically important domains.  
 The inclusion of sudden gains from the first session using the ORS is an important 
adaptation for brief psychological treatments such as CBT for health anxiety, as compared to 
longer-treatments upon which established criteria have been based. It carries the risk of 
including sudden gains that are more likely to have occurred due to random fluctuations in 
score. However, in the current sample, the adapted criteria were more clinically meaningful 
than criteria closer to the original. This may be because fewer sudden gainers were identified 
using the original criteria than has been typical in previous studies. The ORS could be more 
susceptible to random fluctuations in score, which would make it less likely that a statistically 
significant pre-post gain difference would be identified. However, the inclusion of very early 
and very late sudden gains seemed to be the most influential factor in identifying the majority 
of sudden gainers excluded by the strict criteria. The initial sessions of psychological 
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treatment are often considered to be primarily focused on assessment only, but this study and 
other sudden gains research suggest that clinically significant changes can occur very early 
(Busch et al., 2006). Within the treatment offered in the current study, only ‘problem 
identification and prioritization’ is intended to be covered in the first session, yet this 
contributed to significant improvements for some participants. This may be to some degree 
unique to this study, as most patients were unfamiliar with the concept of health anxiety at 
referral and so psychoeducation around this issue might have been an important therapeutic 
step. 
 No significant difference was identified between sudden gainers and the remainder of 
the sample in severity of health anxiety, generalized anxiety, general health, somatic 
symptoms, or quality of life – despite trends of greater improvement. Further research is 
required to establish the meaning of these results. It is possible that ORS sudden gains can 
only predict some specific outcomes but not others amongst patients with health anxiety. It is 
also possible that statistical power may have been lacking in this sample, given that there 
were trends towards greater improvements amongst sudden gainers on all outcomes and the 
original RCT sample-size was not powered for this purpose. Taken together, the current 
results suggest that sudden gains on the ORS may indicate improvements in some domains, 
but, as previously identified, supplementing the ORS with disorder-specific assessment is 
likely to help understand changes of particular interest (Nugter et al., 2017). 
 A key strength of this study is the account it takes of multiple changes over time, as – 
through applying a multilevel modelling design – it does not rely on a specific measurement 
at a particular time-point. As such, the study accounts for trends during and after 
psychotherapy across health domains. This approach has not often been used in sudden gains 
research. 
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Limitations 
Previous ROM studies have often been carried out in usual care settings. This adds two 
elements missing from the current study: Larger, mixed patient samples and large therapist 
samples. In particular, the limited variance amongst the four therapists in this study meant 
that the outcome variance often present in larger therapist samples was absent. However, the 
high rates of multimorbidity, including several mental health problems, suggest that findings 
may be relevant to other patient groups – including mixed usual care populations. This study 
aimed to assess the value of ROM within a patient population where a variety of physical and 
mental health changes would be important – it did not therefore aim to be comprehensive, 
rather it aimed to be illustrative of the value ROM might have for outcomes amongst people 
with difficulties which are hard to monitor using single outcomes. The analysis aimed to 
account for comorbidities by included the total number of disorders into models, but this was 
only a significant predictor of outcome in health anxiety and generalized anxiety. This may 
have been because total number of diagnoses was too crude an assessment of the impact 
multimorbidity can have. 
The criteria used to identify sudden gains have been subject to debate, with no clear 
agreement on the standards to be used in different clinical populations. The Tang and 
DeRubeis (1999) criteria are the most commonly used and the adaptation to include very 
early gains aimed to fit with the general finding that very early changes can be significant. 
The proportion of patients identified as experiencing sudden gains in this study is broadly 
similar to those found in previous studies and the impact is comparable (Aderka et al., 2012). 
However, the null findings on the primary outcome (health anxiety) and some other measures 
suggests that there are important limitations to the value of ROM sudden gains identified in 
the way used. This is particularly important when reducing health anxiety was the primary 
focus and purpose of the psychotherapy in question. Yet, sudden gains on the ORS did not 
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translate into differential gains in health anxiety. Furthermore, the adapted criteria was not 
independently validated prior to testing in this study. The method, therefore requires future 
independent testing. 
Common methods variance was addressed by the study design in some ways, but the 
repeated completion of self-report measure could still have inflated outcome associations. 
This means that the relationship between ORS scores and follow-up outcomes could have 
been over-emphasized by the fact that similar types of assessment were completed by the 
same person at different time points. 
In addition, this study does not give evidence for the effectiveness of ROM per se. It 
cannot establish whether use of ROM improved the therapy offered or not. However, it does 
inform the utility of ROM amongst patients with health anxiety using rigorous methodology. 
Future research and implications 
Future investigations of ROM systems should include a larger sample incorporating 
independent, blinded, multiple assessments during and for a sustained period after 
psychological treatment. The primary outcome should be assessed session-by-session 
alongside any ROM system to give a clearer understanding of their covariance over 
treatment. This would also inform how frequently sudden gains on ROM systems co-occur 
with sudden gains on the primary outcome. It would also aid understanding of the possible 
additive effect of general and disorder-specific ROM. 
Overall, this study suggests that general ROM assessment is specifically relevant to 
high users of health care with severe health anxiety – a patient population who rarely seek 
psychological therapy and a group that healthcare services have struggled to help generally 
(Tyrer, Eilenberg, Fink, Hedman, & Tyrer, 2016). This study also indicates that the ORS 
score at the final session of CBT for severe health anxiety has long-term prognostic value 
across a range of physical and mental health domains. In particular, this is one of the first 
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studies to investigate the relationship between the ORS and quality of life, overall health, 
social functioning or work functioning. In practical terms, this gives more confidence for the 
use of the ORS in services offering psychological therapies for problems that span physical 
and mental health, such as severe health anxiety. This study also emphasizes the value of 
disorder-specific feedback alongside general outcome feedback. For example, during 
treatment a therapist may assume improvement in health anxiety when there is a large stable 
improvement on the ORS, but the findings presented suggest this assumption could be 
incorrect.  
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Table 1. Multilevel model results for the predictive validity of the last session ORS score for 
each clinical outcome 
 
Note. Models for all outcomes included baseline score for the given clinical outcome, session 1 ORS score and 
total number of diagnoses as covariates. Full details of models for each outcome are available in supplementary 
materials. Abbreviations: B: unstandardized β coefficient; SE: standard error; p, predictor statistical significance 
at an alpha of .05; CI, confidence interval; SHAI, short form health anxiety inventory; PHQ-9, patient health 
questionnaire 9-items; GAD-7, generalized anxiety disorder 7-items; PHQ-15, patient health questionnaire 15-
items; WSAS, work and social adjustment scale; EQ5D, Euroqol 5-dimensions 5-levels; VAS, visual analogue 
scale.
Clinical Outcome B SE p 95% CI 
Health Anxiety (SHAI) -0.34 0.19 <.001 -0.51 -0.16 
Generalized Anxiety (GAD-7) -0.33 0.06 <.001 -0.44 -0.21 
Depression (PHQ-9) -0.34 0.07 <.001 -0.49 -0.19 
Somatic symptoms (PHQ-15) -0.19 0.07 .008 -0.33 -0.05 
Functional impairment (WSAS) -0.46 0.13 .001 -0.73 -0.20 
Quality of Life (EQ5D) 0.008 0.003 .021 0.001 0.015 
General health (VAS) -0.19 0.07 .008 -0.33 -0.05 
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Table 2. Pre-post treatment effect sizes and predictive effect sizes for post-treatment 
wellbeing and health anxiety. 
Note. aCohen’s d effect sizes descriptors: 0.2: small; 0.5: Medium ≥0.8: Large. 
Abbreviations: ORS: outcome rating scale; SHAI: Short form health anxiety inventory; PHQ-
9: Patient health questionnaire 9 items; GAD-7: generalized anxiety disorder 7 items; PHQ-
15: patient health questionnaire 15 items; WSAS: work and social adjustment scale; EQ5D-
5L: Euroqol 5 levels; VAS: visual analogue scale. 
 
 
 
 
 
 
 
 
 
 
 
Outcome 
Pre-post 
treatment effect 
size (Cohen's d)a 
% Reduction in 
unexplained variance 
unique to last session ORS 
% Reduction in 
unexplained variance 
unique to 6-month SHAI 
Health anxiety 
(SHAI) 
1.9 30 - 
Generalised anxiety 
(GAD-7) 
1.4 35 29 
Wellbeing (ORS) 1.3 - 11 
Depression (PHQ-9) 0.8 24 27 
General health (VAS) 0.7 15 19 
Somatic Symptoms 
(PHQ-15) 
0.6 11 16 
Functional 
impairment (WSAS) 
0.6 9 10 
Quality of life  
(EQ-5D) 
0.2 10 15 
AVERAGE 0.9 19 18 
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Figure 1. The average sudden gain. The averaged Outcome Rating Scale (ORS) scores are 
shown for the sessions around the pre-gain session (N).   
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Figure 2. Percentage greater outcome improvement achieved by treatment responders with 
sudden gains versus non-sudden gaining treatment responders. 
 
 
Note. *p < .05 **p < .01. Abbreviations: ORS: outcome rating scale; SHAI: Short form 
health anxiety inventory; PHQ-9: Patient health questionnaire 9 items; GAD-7: generalized 
anxiety disorder 7 items; PHQ-15: patient health questionnaire 15 items; WSAS: work and 
social adjustment scale; EQ5D-5L: Euroqol 5 levels; VAS: visual analogue scale. 
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